Management of head and neck carcinomas with synchronous or metachronous oligometastatic disease: Role of locoregional radiotherapy and metastasis-directed radiotherapy

被引：4

作者：

Tonneau, M. ^{[1
]}

Nebbache, R. ^{[2
]}

Larnaudie, A. ^{[3
]}

Thureau, S. ^{[4
,5
,6
]}

Pointreau, Y. ^{[7
]}

Blanchard, P. ^{[8
]}

Thariat, J. ^{[3
,9
]}

机构：

[1] Serv oncol radiotherapie, Serv Oncol Radiotherapie, 3 Rue Frederic Combemale, Lille, France

[2] Hop Europeen Georges Pompidou, Serv Oncol Radiotherapie, Paris, France

[3] Ctr Francois Baclesse, Dept Oncol Radiotherapie, Caen, France

[4] Ctr Henri Becquerel, Dept Radiotherapie & Phys Med, Rouen, France

[5] Univ Rouen, Unite QuantIF Litis EA 4108, Rouen, France

[6] Inst Interreg Cancerol ILC, Dept Imagerie, 64 Rue Degre, F-72000 Le Mans, France

[7] Inst Interreg cancerol ILC, Inst Interreg Cancerol ILC, Ctr Cancerol Sarthe CCS, 64 Rue Degre, F-72000 Le Mans, France

[8] Univ Paris Saclay, Dept Radiat Oncol, Gustave Roussy, Inserm U1018 Oncostat, Villejuif, France

[9] Unicaen Univ Normandie, Lab Phys Corpusculaire IN2P3 CNRS UMR 6534, F-14000 Caen, France

来源：

CANCER RADIOTHERAPIE | 2024年 / 28卷 / 01期

关键词：

Cancer; Squamous cell carcinoma; Head and neck; Oligometastasis; Radiotherapy; SQUAMOUS-CELL CARCINOMA; DISTANT METASTASES; RADIATION-THERAPY; PULMONARY METASTASES; NASOPHARYNGEAL CARCINOMA; RECEIVING CHEMOTHERAPY; RECURRENT; CETUXIMAB; PATTERNS; SURVIVAL;

D O I：

10.1016/j.canrad.2023.03.004

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Head and neck carcinomas are initially metastatic in about 15% of cases. Radiotherapy is a cornerstone in the multimodal strategy at the locoregional phase. In patients with head and neck cancer, often heavily pretreated and with comorbidities, who relapse locoregionally or at distant sites, radiotherapy has also become increasingly important at the metastatic phase. Data on the optimal sequence of systemic treatments and metastasis-directed treatments including stereotactic irradiation are still lacking. Several randomized head and neck trials have been initiated that should provide important answers, including one recent GORTEC trial. (c) 2023 Socie ' te ' franc, aise de radiothe ' rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.

引用

页码：83 / 92

页数：10

共 89 条

[1] Oligometastatic squamous cell carcinoma of the head and neck treated with stereotactic body ablative radiotherapy: Single-institution outcomes [J].

Bates, James E. ;

De Leo, Alexandra N. ;

Morris, Christopher G. ;

Amdur, Robert J. ;

Dagan, Roi .

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2019, 41 (07) :2309-2314

[2] Clinical outcome of stereotactic body radiotherapy for lung-only oligometastatic head and neck squamous cell carcinoma: Is the deferral of systemic therapy a potential goal? [J].

Bonomo, Pierluigi ;

Greto, Daniela ;

Desideri, Isacco ;

Loi, Mauro ;

Di Cataldo, Vanessa ;

Orlandi, Ester ;

Iacovelli, Nicola Alessandro ;

Becherini, Carlotta ;

Visani, Luca ;

Salvestrini, Viola ;

Mariotti, Matteo ;

Livi, Lorenzo .

ORAL ONCOLOGY, 2019, 93 :1-7

[3] Definitive local therapy to head and neck squamous cell carcinoma with distant metastasis [J].

Borson, Steven ;

Shuai, Yongli ;

Branstetter, Barton F. ;

Nilsen, Marci Lee ;

Hughes, Marion A. ;

Fenton, Moon ;

Kubik, Mark ;

Sridharan, Shaum ;

Clump, David A. ;

Skinner, Heath D. ;

Johnson, Jonas T. ;

Chiosea, Simion, I ;

Ohr, James ;

Duvvuri, Umamaheswar ;

Kim, Seungwon ;

Traylor, Katie S. ;

Ferris, Robert ;

Zandberg, Dan P. .

LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY, 2022, 7 (03) :757-765

[4] Pembrolizumab Alone or With Chemotherapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma in KEYNOTE-048: Subgroup Analysis by Programmed Death Ligand-1 Combined Positive Score [J].

Burtness, Barbara ;

Rischin, Danny ;

Greil, Richard ;

Soulieres, Denis ;

Tahara, Makoto ;

de Castro Jr, Gilberto ;

Psyrri, Amanda ;

Brana, Irene ;

Baste, Neus ;

Neupane, Prakash ;

Bratland, Ase ;

Fuereder, Thorsten ;

Hughes, Brett G. M. ;

Mesia, Ricard ;

Ngamphaiboon, Nuttapong ;

Rordorf, Tamara ;

Wan Ishak, Wan Zamaniah ;

Ge, Joy ;

Swaby, Ramona F. ;

Gumuscu, Burak ;

Harrington, Kevin .

JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (21) :2321-+

[5] Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study [J].

Burtness, Barbara ;

Harrington, Kevin J. ;

Greil, Richard ;

Soulieres, Denis ;

Tahara, Makoto ;

de Castro, Gilberto, Jr. ;

Psyrri, Amanda ;

Baste, Neus ;

Neupane, Prakash ;

Bratland, Ase ;

Fuereder, Thorsten ;

Hughes, Brett G. M. ;

Mesia, Ricard ;

Ngamphaiboon, Nuttapong ;

Rordorf, Tamara ;

Ishak, Wan Zamaniah Wan ;

Hong, Ruey-Long ;

Mendoza, Rene Gonzalez ;

Roy, Ananya ;

Zhang, Yayan ;

Gumuscu, Burak ;

Cheng, Jonathan D. ;

Jin, Fan ;

Rischin, Danny .

LANCET, 2019, 394 (10212) :1915-1928

[6] Vertebral metastases from oral squamous cell carcinoma [J].

Carlson, ER ;

Ord, RA .

JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2002, 60 (08) :858-862

[7] Recognition of and treatment recommendations for oligometastatic disease in multidisciplinary tumor boards [J].

Christ, Sebastian M. ;

Heesen, Philip ;

Muehlematter, Urs J. ;

Pohl, Kaspar ;

Thiel, Gabriel William ;

Willmann, Jonas ;

Ahmadsei, Maiwand ;

Kroese, Tiuri E. ;

Mayinger, Michael ;

Balermpas, Panagiotis ;

Wicki, Andreas ;

Andratschke, Nicolaus ;

Huellner, Martin ;

Guckenberger, Matthias .

CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2023, 38 :123-129

[8] Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study [J].

Cohen, Ezra E. W. ;

Soulieres, Denis ;

Le Tourneau, Christophe ;

Dinis, Jose ;

Licitra, Lisa ;

Ahn, Myung-Ju ;

Soria, Ainara ;

Machiels, Jean-Pascal ;

Mach, Nicolas ;

Mehra, Ranee ;

Burtness, Barbara ;

Zhang, Pingye ;

Cheng, Jonathan ;

Swaby, Ramona F. ;

Harrington, Kevin J. .

LANCET, 2019, 393 (10167) :156-167

[9] The 'QUAD SHOT' - a phase II study of palliative radiotherapy for incurable head and neck cancer [J].

Corry, J ;

Peters, LJ ;

D'Costa, I ;

Milner, AD ;

Fawns, H ;

Rischin, D ;

Porceddu, S .

RADIOTHERAPY AND ONCOLOGY, 2005, 77 (02) :137-142

[10] Elective nodal irradiation mitigates local and systemic immunity generated by combination radiation and immunotherapy in head and neck tumors [J].

Darragh, Laurel B. ;

Gadwa, Jacob ;

Pham, Tiffany T. ;

Van Court, Benjamin ;

Neupert, Brooke ;

Olimpo, Nicholas A. ;

Nguyen, Khoa ;

Nguyen, Diemmy ;

Knitz, Michael W. ;

Hoen, Maureen ;

Corbo, Sophia ;

Joshi, Molishree ;

Zhuang, Yonghua ;

Amann, Maria ;

Wang, Xiao-Jing ;

Dow, Steven ;

Kedl, Ross M. ;

Samedi, Von ;

Boss, Mary-Keara ;

Karam, Sana D. .

NATURE COMMUNICATIONS, 2022, 13 (01)

← 1 2 3 4 5 6 7 8 9 →